Related Experiment Video
Updated: Nov 20, 2025

Long Term Intravital Multiphoton Microscopy Imaging of Immune Cells in Healthy and Diseased Liver Using CXCR6.Gfp Reporter Mice
Published on: March 24, 2015
Multi-omic analysis unveils biological pathways in peripheral immune system associated to minimal hepatic
Teresa Rubio1, Vicente Felipo1, Sonia Tarazona2
1Laboratory of Neurobiology, Centro Investigación Príncipe Felipe, Valencia, Spain.
Abstract:
Patients with liver cirrhosis may develop minimal hepatic encephalopathy (MHE) which affects their quality of life and life span. It has been proposed that a shift in peripheral inflammation triggers the appearance of MHE. However, the mechanisms involved in this immune system shift remain unknown. In this work we studied the broad molecular changes involved in the induction of MHE with the goal of identifying (1) altered genes and pathways in peripheral blood cells associated to the appearance of MHE, (2) serum metabolites and cytokines with modified levels in MHE patients and (3) MHE-regulated immune response processes related to changes in specific serum molecules. We adopted a multi-omic approach to profile the transcriptome, metabolome and a panel of cytokines of blood samples taken from cirrhotic patients with or without MHE. Transcriptomic analysis supports the hypothesis of alternations in the Th1/Th2 and Th17 lymphocytes cell populations as major drivers of MHE. Cluster analysis of serum molecules resulted in six groups of chemically similar compounds, suggesting that functional modules operate during the induction of MHE. Finally, the multi-omic integrative analysis suggested a relationship between cytokines CCL20, CX3CL1, CXCL13, IL-15, IL-22 and IL-6 with alteration in chemotaxis, as well as a link between long-chain unsaturated phospholipids and the increased fatty acid transport and prostaglandin production. We found altered immune pathways that may collectively contribute to the mild cognitive impairment phenotype in MHE. Our approach is able to combine extracellular and intracellular information, opening new insights to the understanding of the disease.
Insights
Minimal hepatic encephalopathy (MHE) in liver cirrhosis patients involves immune system shifts. This study reveals altered immune pathways and molecular changes linked to MHE, offering new insights into cognitive impairment.
Area of Science:
- Immunology
- Hepatology
- Molecular Biology
Background:
- Minimal hepatic encephalopathy (MHE) impacts liver cirrhosis patients' quality of life and survival.
- Peripheral inflammation shifts are implicated in MHE development, but underlying mechanisms are unclear.
Purpose of the Study:
- Investigate broad molecular changes in MHE.
- Identify altered genes, pathways, serum metabolites, and cytokines in MHE patients.
- Explore MHE-regulated immune responses linked to serum molecule changes.
Main Methods:
- Multi-omic approach: transcriptomic, metabolomic, and cytokine profiling of blood samples.
- Analysis of cirrhotic patients with and without MHE.
- Integration of extracellular and intracellular data.
Main Results:
- Transcriptomics indicate Th1/Th2/Th17 lymphocyte alterations in MHE.
- Six serum molecule clusters suggest functional modules in MHE induction.
- Specific cytokines (CCL20, CX3CL1, CXCL13, IL-15, IL-22, IL-6) linked to chemotaxis alterations.
- Long-chain unsaturated phospholipids associated with fatty acid transport and prostaglandin production.
Conclusions:
- Altered immune pathways contribute to MHE's mild cognitive impairment phenotype.
- Multi-omic integration provides novel insights into MHE pathogenesis.
- Findings open new avenues for understanding and potentially treating MHE.
More Related Videos
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...

